Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Central Nervous System Neoplasms 37Glioblastoma 23Gliosarcoma 20Astrocytoma 11Brain Neoplasms 10Glioma 6Neuroblastoma 5Oligodendroglioma 4Medulloblastoma 4Head and Neck Neoplasms 3Esthesioneuroblastoma, Olfactory 3Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Ependymoma 2Teratoma 1Spinal Cord Neoplasms 1Radiation Injuries 1Ototoxicity 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Lymphoma 1Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 19Bevacizumab 14Irinotecan 12Carboplatin 10Cyclophosphamide 9Radiosurgery 8Lomustine 8Radiotherapy 7pembrolizumab 6Vincristine 6Topotecan 6Drug Therapy 6Surgical Procedures, Operative 5Etoposide 5Doxorubicin 5Cisplatin 53-Iodobenzylguanidine 5trametinib 4Metformin 4Gemcitabine 4Dexamethasone 4Blood Specimen Collection 4poly ICLC 3dabrafenib 3Vorinostat 3Trastuzumab 3Therapeutics 3Radiation 3Paclitaxel 3Observation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Chemotherapy, Adjuvant × CNS × Clear all
NCT00107003 2018-07-05

GW572016 to Treat Recurrent Malignant Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
9 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡